Organon (OGN) Tax Provisions (2020 - 2026)
Organon (OGN) recorded quarterly Tax Provisions of $67.0 million in Q1 2026, up 17.54% quarter-over-quarter from $57.0 million in Q4 2025, and up 378.57% on a YoY basis from $14.0 million in Q1 2025.
Organon (OGN) Tax Provisions (2020 - 2026) Analysis & Trends
Organon's Tax Provisions history runs 7 years deep, the most recent figure standing at $67.0 million for Q1 2026.
- In Q1 2026, Tax Provisions rose 378.57% year-over-year to $67.0 million; the TTM figure through Mar 2026 stood at $291.0 million (up 473.08% YoY), while the FY2025 annual figure was $238.0 million, up 517.54% from the prior year.
- Tax Provisions was $67.0 million for Q1 2026 at Organon, up from $57.0 million in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $94.0 million in Q1 2022 to a low of -$442.0 million in Q4 2023.
- Historically, Tax Provisions has averaged $7.1 million across 5 years, with a median of $40.0 million in 2024.
- The sharpest annual moves came in 2022 and 2023: Tax Provisions jumped 783.33% in 2022, then sank 2204.76% in 2023.
- A 5-year view of Tax Provisions shows it stood at $21.0 million in 2022, then tumbled by 2204.76% to -$442.0 million in 2023, then surged by 104.52% to $20.0 million in 2024, then surged by 185.0% to $57.0 million in 2025, then gained by 17.54% to $67.0 million in 2026.
- The last three Tax Provisions figures came in at $67.0 million (Q1 2026), $57.0 million (Q4 2025), and $83.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 93,026,132.38 Bn | 93,026,127.42 Bn | 7.76 Bn | -411.19 Mn |
| 2 | Eli Lilly | 1,022.62 Bn | 1,017.34 Bn | 16.22 Bn | 1.45 Bn |
| 3 | Johnson & Johnson | 570.65 Bn | 548.59 Bn | 15.96 Bn | 755.00 Mn |
| 4 | AbbVie | 398.73 Bn | 389.38 Bn | 10.78 Bn | 342.00 Mn |
| 5 | Merck | 295.53 Bn | 289.88 Bn | 12.09 Bn | 709.00 Mn |
| 6 | Amgen | 186.30 Bn | 174.26 Bn | 5.87 Bn | 265.00 Mn |
| 7 | Gilead Sciences | 155.93 Bn | 148.21 Bn | 5.52 Bn | 559.00 Mn |
| 8 | Pfizer | 146.09 Bn | 133.32 Bn | -1.21 Bn | 461.00 Mn |
| 9 | Bristol Myers Squibb | 114.98 Bn | 104.53 Bn | 8.07 Bn | 561.00 Mn |
| 10 | Organon | 3.49 Bn | 2.37 Bn | 783.00 Mn | 67.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 67.00 Mn |
| Dec 31, 2025 | 57.00 Mn |
| Sep 30, 2025 | 83.00 Mn |
| Jun 30, 2025 | 84.00 Mn |
| Mar 31, 2025 | 14.00 Mn |
| Dec 31, 2024 | 20.00 Mn |
| Sep 30, 2024 | -152.00 Mn |
| Jun 30, 2024 | 40.00 Mn |
| Mar 31, 2024 | 35.00 Mn |
| Dec 31, 2023 | -442.00 Mn |
| Sep 30, 2023 | 22.00 Mn |
| Jun 30, 2023 | 12.00 Mn |
| Mar 31, 2023 | 58.00 Mn |
| Dec 31, 2022 | 21.00 Mn |
| Sep 30, 2022 | 55.00 Mn |
| Jun 30, 2022 | 53.00 Mn |
| Mar 31, 2022 | 94.00 Mn |
| Dec 31, 2021 | 34.00 Mn |
| Sep 30, 2021 | 66.00 Mn |
| Jun 30, 2021 | 6.00 Mn |